Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Vera Therapeutics, Inc. | 2,187,504 | reported | 18 May 2021 | tx 3+2,914,776−2,187,504 |
| Entasis Therapeutics Holdings Inc. | 842,454 | reported | 28 Sept 2018 | tx 5+1,155,416−16,949,153 |
| Galera Therapeutics, Inc. | 64,000 | reported | 14 Jun 2023 | tx 5+130,134 |
| SEATTLE GENETICS INC /WA | 42,552 | reported | 29 Jun 2004 | tx 122+10,000−1,132,931 |
| Bicara Therapeutics Inc. | 23,746 | reported | 09 Jun 2025 | tx 1+23,746 |
| Orexigen Therapeutics, Inc. | 20,000 | reported | 02 Jun 2011 | tx 66+2,900,354−8,468,565 |
| THRESHOLD PHARMACEUTICALS INC | 15,000 | reported | 13 May 2008 | tx 14+105,000−2,622,000 |
| Mirna Therapeutics, Inc. | 10,000 | reported | 05 Jun 2019 | tx 13+3,182,011−1,827,828 |
| CORGENTECH INC | 10,000 | reported | 09 May 2008 | tx 11+4,958,226 |
| Trius Therapeutics Inc | 9,302 | reported | 26 Mar 2012 | tx 15+3,793,496−19,929,124 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Jun 2025 | GRANT_AWARD | Bicara Therapeutics Inc. | 23,746 | 0.00 USD | deriv |
| 14 Jun 2023 | GRANT_AWARD | Galera Therapeutics, Inc. | 64,000 | 0.00 USD | deriv |
| 15 Jun 2022 | GRANT_AWARD | Galera Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 31 May 2022 | OTHER | Checkmate Pharmaceuticals, Inc. | 30,000 | — | deriv |
| 31 May 2022 | OTHER | Checkmate Pharmaceuticals, Inc. | 30,000 | — | deriv |
| 31 May 2022 | OTHER | Checkmate Pharmaceuticals, Inc. | 10,030 | — | deriv |
| 09 Aug 2021 | GRANT_AWARD | Checkmate Pharmaceuticals, Inc. | 30,000 | 0.00 USD | deriv |
| 16 Jun 2021 | GRANT_AWARD | Checkmate Pharmaceuticals, Inc. | 10,030 | 0.00 USD | deriv |
| 16 Jun 2021 | GRANT_AWARD | Galera Therapeutics, Inc. | 13,179 | 0.00 USD | deriv |
| 18 May 2021 | CONVERSION | Vera Therapeutics, Inc. | 2,187,504 | — | |
| 18 May 2021 | PURCHASE | Vera Therapeutics, Inc. | 727,272 | 11.00 USD | first after silence |
| 18 May 2021 | CONVERSION | Vera Therapeutics, Inc. | 2,187,504 | 0.00 USD | deriv |
| 10 Nov 2020 | GRANT_AWARD | Checkmate Pharmaceuticals, Inc. | 30,000 | 0.00 USD | deriv |
| 09 Jun 2020 | GRANT_AWARD | Galera Therapeutics, Inc. | 13,179 | 0.00 USD | deriv |
| 21 Jan 2020 | GRANT_AWARD | Iterum Therapeutics plc | — | 1750000.00 USD | deriv |
| 06 Nov 2019 | GRANT_AWARD | Galera Therapeutics, Inc. | 19,776 | 0.00 USD | deriv |
| 05 Jun 2019 | GRANT_AWARD | Mirna Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 28 Sept 2018 | CONVERSION | Entasis Therapeutics Holdings Inc. | 458,425 | — | |
| 28 Sept 2018 | PURCHASE | Entasis Therapeutics Holdings Inc. | 337,724 | 15.00 USD | first after silence |
| 28 Sept 2018 | CONVERSION | Entasis Therapeutics Holdings Inc. | 359,267 | — | |
| 28 Sept 2018 | CONVERSION | Entasis Therapeutics Holdings Inc. | 9,502,249 | 0.00 USD | deriv |
| 28 Sept 2018 | CONVERSION | Entasis Therapeutics Holdings Inc. | 7,446,904 | 0.00 USD | deriv |
| 13 Jun 2018 | GRANT_AWARD | Mirna Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 26 Jan 2018 | GRANT_AWARD | Mirna Therapeutics, Inc. | 150,000 | 9.75 USD | |
| 29 Dec 2017 | GRANT_AWARD | Mirna Therapeutics, Inc. | 18,572 | 0.00 USD | deriv |
6 purchases reported after at least 12 months of silence — most recent on 18 May 2021.